Collection-image

TOPICAL COLLECTIONS

Cutting-edge Technologies to Study Healthy and Malignant Hematopoiesis

 

Submit Abstract

Guest Editor

Pia Sommerkamp

Pia Sommerkamp

European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Dr. Pia Sommerkamp is a Postdoctoral Fellow, supported by the Peter and Traudl Engelhorn foundation, in the group of Dr. Matthias Hentze at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Her research focuses on RNA-protein interactions and their functional role in stem cell self-renewal and differentiation. She holds a Bachelor of Science degree in Molecular Biomedicine from the University of Bonn and a Master of Science degree in Molecular Biosciences, Major Cancer Biology from the University of Heidelberg. In 2016, she joined the lab of Dr. Andreas Trumpp at the German Cancer Research Center (DKFZ) as a Ph.D. student and studied lncRNAs in hematopoietic stem cells and the role of alternative polyadenylation in hematopoiesis. After receiving her Ph.D. in 2019, for which she was awarded the Wilma Moser-Prize, her work focused on molecular profiling and functional analysis of novel hematopoietic progenitor subsets by combining technologies such as RNA-seq, SiC-RNA-seq and mouse bone marrow transplantation. In addition, Dr. Pia Sommerkamp is an active member of the International Society for Experimental Hematology (ISEH) New Investigators Committee.

Collection Overview

Hematopoietic stem and progenitor cells (HSPCs) reside primarily in the bone marrow (BM) and represent the top of a tightly controlled differentiation cascade, which ensures lifelong generation of functional blood cells. Hematopoiesis is regulated by intracellular signaling cascades and extracellular cues, and accumulation of mutations in the HSC or progenitor pool can lead to the development of hematologic diseases such as leukemia. In recent years, cutting-edge technologies have been developed that can be used to study the mechanisms governing normal and malignant hematopoiesis. These include novel tools for Omics analysis of those scarce cell types on a transcriptional, epigenetic, translational, proteomic and metabolomic level. In addition, barcoding techniques have been developed that allow tracing of cell fate and differentiation kinetics in vitro and in vivo. Several imaging technologies have been established to study the localization of HSPCs in the BM and to tackle HSPC-niche cell interactions. Recently, spatial-transcriptomic profiling and CRISPR-based approaches have extended the existing pool of protocols to facilitate the study of hematopoietic cell subsets. This collection provides an overview of state-of-the-art technologies to study hematopoiesis. 

Articles

Simultaneous Assessment of Kinship, Division Number, and Phenotype <em>via</em> Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

0 Views

•

Cited by 1

•

2023

•

<em>Ex Vivo</em> Expansion and Genetic Manipulation of Mouse Hematopoietic Stem Cells in Polyvinyl Alcohol-Based Cultures
7:55

Ex Vivo Expansion and Genetic Manipulation of Mouse Hematopoietic Stem Cells in Polyvinyl Alcohol-Based Cultures

0 Views

•

Cited by 2

•

2023

•

Abstracts

Comprehensive optimization approach for a LC-MS-based targeted metabolomics on rare, FACS-purified cell types

Jörg Büscher*1,

Manuel Stecher1,

Konrad Schuldes1,

Tim Lämmermann1,

Michael Mitterer1,

Sebastian Hobitz1,

Angelika Rambold1,

Katharina Schönberger1,

Nina Cabezas Wallscheid1

1Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany